Wire · operational-macro
China plans to transform $3M biotech sector into $522B powerhouse by 2030
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 19 September 2026 · Fusion42 review
China's new five-year biotech plan aims to grow its biotech sector from $3 million to $522 billion by 2030, with goals including 25% of global first-in-class drugs originating in China and at least five Chinese-developed blockbuster medicines.
This Wire brief sits within Fusion42's coverage of Biotech.
◆ ◆ The Wire takeaway
China's biotech sector is set to become a dominant global force, shifting the market dynamics and raising the bar for innovation-driven drug development. If you work in biotech innovation, this expansion means new competition and potential collaboration pathways emerging rapidly.
◆ Coverage
1 source · 18 Sep 2026
◆ Related on Wire
◆ Topics